Hello,

Would anyone be willing to share your Push Dose Pressor policy and procedure? Is the Emergency Department included in the policy? Thank you

Tiffany Knight, PharmD, Corporate Medication Safety Risk Manager

Tiffany.Knight@uhsinc.com

Hello colleagues,

BCMA rates in our radiology departments are low. The primary reason is workflow (being unable to scan at point of care) during imaging studies. At the risk of promoting workarounds, has anyone developed any successful strategies to improve BCMA rates in radiology?

Thank you,
Megan Fragale, PharmD, MS, BCPS
Medication Safety Officer
Skagit Regional Health

Hello colleagues,

For pediatric code support, my institution makes Broselow color coded dose stickers that are placed on common code medications. Pharmacy places the stickers on the drug boxes and has repeatedly mislabeled some of the drugs. Given the other code resources available to staff (including Broselow tape), I am inclined to advise against the addition of this sticker to the drug boxes to prevent future errors.

Good afternoon,

I would love to hear you experience in implementing safety strategies to multiple sites.

Where I am, often the large academic center struggles to put things into place due to the sheer size and operational issues that they have. They often ask to opt out.

As I navigate this issue, Id like to know what others are finding,

Please take this shot 3 question survey- Ill post the results.
https://www.surveymonkey.com/r/L5G25TW

I am hoping to find out if anyone has had success in turning on duplicate therapy alerts without causing too much alert fatigue?

For context, (I am on Epic) we currently have the out of the box duplicate alerts shut off, but have built a handful of high risk duplicate rules that will alert for certain drugs/categories. This doesn't seem to be enough to catch all potentially harmful duplicates.

Thank you!

Just learned my facility will transition to a program called IRIS to track our ADRs. Does anyone else use this and have any tips/helpful info? Thank you!

Hi all,  

We are in the process of updating the limits within our smart pump drug library, and I am curious what other institutions are doing to define hard limits.  

What is your approach to setting hard limits in the drug library for intermittent infusions? Specifically inquiring about hard minimum duration limits and hard maximum dosing limits. Do you use a percentage-based rule? For example: Maximum dose for cefepime is 2000mg and establishing a hard maximum dose in the drug library would be 3000mg if using 50%.  

Background: our respiratory therapy dept was previously using Medfusion syringe pumps for drugs in Aerogen syringes (epoprostenol, ribavirin, etc.), until those pumps were recalled a few months ago, and they were told they had to switch to a different pump. We use Alaris pumps for our IV infusions, and they switched over to Alaris and are currently running these in basic mode.

I'm wondering if anyone has experience/advice to share on this?

Good afternoon,

Hi All